Corrigendum
Corrigendum to “Comparison of neoadjuvant cisplatin-based
chemotherapy versus radiochemotherapy followed by resection
for stage III (N2) NSCLC” [Eur J Cardiothorac Surg 27 (2005) 1092–1098]
*
,**
Edgardo Pezzetta
a, Roger Stupp
b, Abderrahim Zouhair
c, Louis Guillou
d, Patrick Taffe
´
e,
Christian von Briel
f, Thorsten Krueger
a, Hans-Beat Ris
a,*
aDepartment of Thoracic Surgery, Centre Hospitalier Universitaire Vaudois, University of Lausanne, CH-1011 Lausanne, Switzerland bDepartment of Medical Oncology, University of Lausanne, Lausanne, Switzerland
cDepartment of Radio-Oncology, University of Lausanne, Lausanne, Switzerland dDepartment of Pathology, University of Lausanne, Lausanne, Switzerland eDepartment of Biostatistics, University of Lausanne, Lausanne, Switzerland
fDepartment of Radio-Oncology, University of Bern, Bern, Switzerland
The authors and publisher regret to announce that the Acknowledgement section was omitted in the original published article
above. Please find the missing section below:
Acknowledgements
The Swiss Institute for Applied Cancer Research has contributed to the data raising in some patients included in our
study. We acknowledge the participation of the Swiss Institute for Applied Cancer Research on this report.
We regret that this has not been mentioned in the original published article.
European Journal of Cardio-thoracic Surgery 28 (2005) 368
www.elsevier.com/locate/ejcts
*
DOI of original article: 10.1016/j.ejcts.2005.02.035 **
Presented at the joint 18th Annual Meeting of the European Association for Cardio-thoracic Surgery and the 12th Annual Meeting of the Europen Society of Thoracic Surgeons, Leipzig, Germany, September 12–15, 2004.
* Corresponding author. Tel.: C41 21 314 24 08; fax: C41 21 314 23 58. E-mail address: hans-beat.ris@chuv.hospvd.ch (H.-B. Ris).
1010-7940/$ - see front matter Q 2005 Elsevier B.V. All rights reserved. doi:10.1016/j.ejcts.2005.06.029
